Texas High Court Overturns Vioxx Award
August 29, 2011
DOCUMENTS
- Opinion
AUSTIN, Texas - The Texas Supreme Court has overturned a $7.75 million Vioxx award, ruling that the plaintiff did not present sufficiently reliable evidence that the painkiller caused a Texas man's heart attack. Merck & Co. v. Garza, No. 09-0073 (Texas Sup. Ct.).
In an Aug. 26 opinion authored by Justice Nathan L. Hecht, the panel ruled that plaintiffs' evidence did not meet the causation requirements set forth in Merrell Dow Pharmaceuticals Inc. v. Havner (953 S.W.2d 706 [Tex. 1997]).
Felicia Garza sued Merck following her husband's April 2001 heart attack, which she blamed on Vioxx prescribed by his cardiologist …
UPCOMING CONFERENCES
HarrisMartin's New Jersey Asbestos Litigation Conference
February 27, 2025 - New Brunswick, NJ
Hyatt Regency New Brunswick
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach